Home > Insider Trading > Filing (0000921895-23-000200)

Filing Details

Accession Number:: 0000921895-23-000200
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-26 13:05:33
Reporting Period:: 2023-01-24

Accepted Time:: 2023-01-26 13:05:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
910267	Titan Pharmaceuticals Inc	TTNP	Biological Products, (No Disgnostic Substances) (2836)	943171940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817604	Activist Investing Llc	1185 Avenue Of The Americas, 3Rd Floor. New York NY 10036		No	No	No	Yes
1932843	E. David Lazar	Villa 1, 14-43Rd Street Jumeirah 2 Dubai C0 00000	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2023-01-24	37,500	$0.97	3,368,902	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2023-01-25	20,000	$1.00	3,388,902	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	359,066	Indirect	By Activist Investing LLC

Footnotes

Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.9591 to $0.98. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $0.97 to $1.01. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote.
Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.